“Your puzzles do indeed show some promise, due to the fact that they engage persons with their emotional and recognition memory, but then rely upon “here and now” problem-solving skills.” Mitchell Slutzky, Ph.D., Clinical Geropsychologist, NY Program demonstrating Memory Cards and Memory Jogging Puzzles with themes by Norman Rockwell and The Saturday Evening Post. These memory activities are fun to do and beneficial for elderly, Alzheimer and Dementia patients. Caregivers and families say they are great for engaging their loved ones in conversation. For more information visit: www.memoryjoggingpuzzles.com
Speech by Pat the Cope Gallagher MEP (ALDE ADLE) on : European initiative on Alzheimer’s disease and other dementias – Asthma inhalers [MEP Speech] [Language EN original] Gallagher-OR_110118_184731_mesp_en
Speech by Jorgo Chatzimarkakis MEP (ALDE ADLE) on : European initiative on Alzheimer’s disease and other dementias – Asthma inhalers [MEP Speech] [Language DE original] Chatzimarkakis-OR_110118_183717_mesp_de
Speech by Antonyia Parvanova MEP (ALDE ADLE) on : European initiative on Alzheimer’s disease and other dementias – Asthma inhalers [MEP Speech] [Language EN original] Parvanova-OR_110118_182923_mesp_en
Speech by Frédérique Ries MEP (ALDE ADLE) on : European initiative on Alzheimer’s disease and other dementias – Asthma inhalers [on behalf of the Group] [Language FR original] Ries-OR_110118_181443_obog_fr
Project4awesome: www.youtube.com What is Alzheimer’s? www.alz.org Donate! www.alz.org Please share and like this video! Make sure to check out others as well!
Dr. Michael Wolfe of the Laboratory for Experimental Alzheimer Drugs at Harvard Medical School and Brigham & Women’s Hospital talks to Adam about the biochemistry underlying Alzheimer’s disease (AD). AD is a neurodegenerative disease associated with plaques and tangles in the brain formed by two proteins, amyloid β (Aβ) and tau, that damage and eventually destroy brain cells. Wolfe and his lab study the mechanism responsible for producing Aβ, which builds up over time and comes to negatively affect the parts of the brain essential for memory and cognition. As the brain ages, it becomes less able to clear out Aβ; as result, Wolfe asserts that the increase in life expectancy worldwide will lead to an exponential rise in cases of AD. Knowledge of the proteins responsible for the development of AD is leading to novel approaches to treating the disease, some of which have gone into clinical trals. Join Adam as he learns the biochemistry behind this growing disease as well as potential therapies to treating it. [04:34]